Literature DB >> 34166743

Prognostic Association of Frailty with Post-Arrest Outcomes Following Cardiac Arrest: A Systematic Review and Meta-Analysis.

Fabrice I Mowbray1, Donna Manlongat2, Andrew P Costa3, Rebecca H Correia4, Lauren E Griffith5, Ryan P Strum6, Matthew Douma7, Shannon M Fernando8, Jerry P Nolan9, Daniel McIsaac10, John Muscedere11, Kerstin de Wit12, Rachel Couban13, Andrew Worster14, Farid Foroutan15.   

Abstract

OBJECTIVE: To synthesize the current evidence examining the association between frailty and a series of post-arrest outcomes following the provision of cardiopulmonary resuscitation (CPR). DATA SOURCES: We searched MEDLINE, PubMed (exclusive of MEDLINE), EMBASE, CINAHL, and Web of Science from inception to August 2020 for observational studies that examined an association between frailty and post-arrest health outcomes, including in-hospital and post-discharge mortality. We conducted citation tracking for all eligible studies. STUDY SELECTION: Our search yielded 20,480 citations after removing duplicate records. We screened the title, abstract and full-texts independently and in duplicate. DATA EXTRACTION: The prognosis research strategy group (PROGRESS) and the critical appraisal and data extraction for systematic review of prediction modelling studies (CHARMS) guidelines were followed. Study and outcome-specific risk of bias were assessed using the QUIPS (Quality in Prognosis Studies) instrument. We rated the certainty of evidence using the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) recommendations for prognostic factor research. DATA SYNTHESIS: Four studies were included in this review and three were eligible for statistical pooling. Our sample comprised 1,134 persons who experienced in-hospital cardiac arrest (IHCA). The mean age of the sample was 71 years. The study results were pooled according to the specific frailty instrument. Three studies used the Clinical Frailty Scale (CFS) and adjusted age (our minimum confounder); the presence of frailty was associated with an approximate three-fold increase in the odds of dying in-hospital after IHCA (aOR = 2.93; 95% CI = 2.43-3.53, high certainty). Frailty was also associated with decreased incidence of ROSC (return of spontaneous circulation) and discharge home following IHCA. One study with high risk of bias used the Hospital Frailty Risk Score and reported a 43% decrease in the odds of discharge home for patients with frailty following IHCA.
CONCLUSION: High certainty evidence was found for an association between frailty and in-hospital mortality following IHCA. Frailty is a robust prognostic factor that contributes valuable information and can inform shared-decision making and policies surrounding advance care directives. Registration: PROSPERO Registration # CRD42020212922.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cardiopulmonary resuscitation; cardiac arrest; frailty; prognosis

Year:  2021        PMID: 34166743     DOI: 10.1016/j.resuscitation.2021.06.009

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  3 in total

1.  Outcomes in adults living with frailty receiving cardiopulmonary resuscitation: A systematic review and meta-analysis.

Authors:  Joseph Hamlyn; Charlotte Lowry; Thomas A Jackson; Carly Welch
Journal:  Resusc Plus       Date:  2022-07-01

2.  Accuracy of prehospital clinicians' perceived prognostication of long-term survival in critically ill patients: a nationwide retrospective cohort study on helicopter emergency service patients.

Authors:  Anssi Heino; Johannes Björkman; Miretta Tommila; Timo Iirola; Helena Jäntti; Jouni Nurmi
Journal:  BMJ Open       Date:  2022-05-17       Impact factor: 3.006

3.  The clinical frailty scale predicts 1-year mortality in emergency department patients aged 65 years and older.

Authors:  Marco Rueegg; Søren Kabell Nissen; Mikkel Brabrand; Tobias Kaeppeli; Thomas Dreher; Christopher R Carpenter; Roland Bingisser; Christian H Nickel
Journal:  Acad Emerg Med       Date:  2022-04-23       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.